1. Homepage
  2. Equities
  3. Germany
  4. Deutsche Boerse AG
  5. SYNLAB AG
  6. News
  7. Summary
    SYAB   DE000A2TSL71

SYNLAB AG

(SYAB)
  Report
Delayed Deutsche Boerse AG  -  05/27 02:02:20 am EDT
18.01 EUR   +2.62%
05/25SYNLAB : JP Morgan remains Neutral
MD
05/13SYNLAB : Receives a Buy rating from Deutsche Bank
MD
05/13SYNLAB : JP Morgan sticks Neutral
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about SYNLAB AG
05/25SYNLAB : JP Morgan remains Neutral
MD
05/13SYNLAB : Receives a Buy rating from Deutsche Bank
MD
05/13SYNLAB : JP Morgan sticks Neutral
MD
05/12SYNLAB : Barclays reiterates its Buy rating
MD
05/12TRANSCRIPT : SYNLAB AG, Q1 2022 Earnings Call, May 12, 2022
CI
05/12SYNLAB : Gets a Neutral rating from JP Morgan
MD
05/12SYNLAB : Jefferies reaffirms its Buy rating
MD
05/12SYNLAB reports a strong start to the fiscal year 2022
EQ
05/12SYNLAB AG Revises Earnings Guidance for 2022
CI
05/12SYNLAB AG Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/10SYNLAB AG : SYNLAB Medical Congress: making healthcare future-proof with advanced diagnost..
EQ
05/09SYNLAB AG : Notification and public disclosure of transactions by persons
EQ
05/09Disclosure on share buy-back according to Article 2 (1) of the Delegated Regulation (EU..
EQ
05/01Certain Ordinary Bearer Shares of SYNLAB AG are subject to a Lock-Up Agreement Ending o..
CI
04/29SYNLAB AG : Notification and public disclosure of transactions by persons
EQ
More most relevant news
All news about SYNLAB AG
05/25SYNLAB : JP Morgan remains Neutral
MD
05/13SYNLAB : Receives a Buy rating from Deutsche Bank
MD
05/13SYNLAB : JP Morgan sticks Neutral
MD
05/12SYNLAB : Barclays reiterates its Buy rating
MD
05/12TRANSCRIPT : SYNLAB AG, Q1 2022 Earnings Call, May 12, 2022
CI
05/12SYNLAB : Gets a Neutral rating from JP Morgan
MD
05/12SYNLAB : Jefferies reaffirms its Buy rating
MD
05/12SYNLAB reports a strong start to the fiscal year 2022
EQ
05/12SYNLAB AG Revises Earnings Guidance for 2022
CI
05/12SYNLAB AG Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
More news
News in other languages on SYNLAB AG
05/12Laborspezialist Synlab erhöht Umsatzziel für 2022
05/12SYNLAB mit starkem Auftakt in das Geschäftsjahr 2022
05/12SYNLAB mit starkem Auftakt in das Geschäftsjahr 2022
05/12SYNLAB AG révise ses prévisions de bénéfices pour 2022
05/12SYNLAB AG annonce ses résultats pour le premier trimestre clos le 31 mars 2022
05/10SYNLAB AG : SYNLAB Medical Congress: Zukunftsfähige Gesundheitsversorgung durch fortschrit..
05/10SYNLAB AG : SYNLAB Medical Congress: Zukunftsfähige Gesundheitsversorgung durch fortschrit..
05/09SYNLAB AG : Meldung und öffentliche Bekanntgabe der Geschäfte von Personen
05/09Synlab ag
05/09Mitteilung über einen Aktienrückkauf gemäß Artikel 2 Abs. 1 der Delegierten Verordnung ..
More news
Analyst Recommendations on SYNLAB AG
05/25SYNLAB : JP Morgan remains Neutral
MD
05/13SYNLAB : Receives a Buy rating from Deutsche Bank
MD
05/13SYNLAB : JP Morgan sticks Neutral
MD
05/12SYNLAB : Barclays reiterates its Buy rating
MD
05/12SYNLAB : Gets a Neutral rating from JP Morgan
MD
More recommendations
Press releases
05/12SYNLAB reports a strong start to the fiscal year 2022
EQ
05/10SYNLAB AG : SYNLAB Medical Congress: making healthcare future-proof with advanced diagnost..
EQ
05/09SYNLAB AG : Notification and public disclosure of transactions by persons
EQ
05/09Disclosure on share buy-back according to Article 2 (1) of the Delegated Regulation (EU..
EQ
04/29SYNLAB AG : Notification and public disclosure of transactions by persons
EQ
More press releases
Upcoming event on SYNLAB AG